Study of ALXN2050 in Participants With Renal Impairment
Clinical trial NCT04623710 · COMPLETED
Trial details
- NCT number
- NCT04623710
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-08
- Primary completion
- 2022-02-18
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.